Beat Steffen is the Managing Director of the Novartis Venture Fund and has extensive experience in the biotechnology and healthcare sectors. They currently serve on the boards of Vivet Therapeutics, Rappta Therapeutics, SpliceBio, and binx health, having previously held a board position at the UZH Life Sciences Fund and Aelin Therapeutics. Beat's background includes significant roles at Novartis, including General Manager of Serelaxin, and a Senior Associate position at McKinsey & Company. They earned a Medical Doctor degree from the University of Zurich and an MBA in Finance from INSEAD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices